Juvenile myelomonocytic leukemia (JMML) is a rare and aggressive childhood cancer associated with mutations in the RAS/MAPK signaling pathway, including NF1 mutations, found in 22% of cases according to a recent study using a 51gene myeloid panel [68]. Here, NF1 is linked to childhood malignant neoplasm.